PATENT CLAIM ANALYSIS

Application Number: 15903559
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "018000"]

Abstract:
The present invention relates generally to a method of modulating glutathione metabolism in the central nervous system of mammals and to agents for use therein. More particularly, the present invention relates to a method of up-regulating glutathione metabolism in the central nervous system by up-regulating levels of glutathione precursor molecules. The method of the present invention is particularly useful, inter alia, in the treatment and/or prophylaxis of conditions characterised by aberrant, unwanted or otherwise inappropriate central nervous system oxidation homeostasis including, but not limited to, schizophrenia.

Claim (Index 13):
The method according to  claim 13  wherein said neuropsychiatric disorder is schizophrenia, psychosis, bipolar disorder, manic depression, affective disorder, or schizophreniform or schizoaffective disorders, psychotic depression, drug induced psychosis, delirium, alcohol withdrawal syndrome or dementia induced psychosis.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 88.0
- Lexical Diversity: 1.79245
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14535855', '15459840', '14535953', '13455155', '15481728']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7533847739316282
- 35 USC 102 Novelty (BERT): 0.4859347712652769
- Combined Prediction Score: 0.7266397736649931
- Mean Citation Score: 184.048734
- Max Citation Score: 201.28696
- Similarity Product: 152.35977742136

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test